Drugs that are considered standard and investigational therapies for myelodysplastic syndromes (MDS) are listed below, please click on their names for more information:
Generic Name | Brand Name |
---|---|
amifostine |
Ethyol |
anti-thymocyte globulin (ATG, ALG) |
Atgam, Thymoglobulin |
arsenic trioxide |
Trisenox |
azacitidine |
Vidaza |
cyclosporine |
Neoral, Sandimmune |
darbepoetin alfa |
Aranesp |
decitabine |
Dacogen |
epoetin alfa (Erythropoietin) |
Epogen, Procrit |
filgrastim (G-CSF) |
Neupogen |
lenalidomide |
Revlimid |
mycophenolate mofetil |
Cellcept |
Zarnestra, Tipifarnib |
|
R115777 | |
sargramostim (GM-CSF) |
Leukine |
TLK-199 |
Telintra |
thalidomide |
Thalomid |
VNP40101M |
Cloretazine |
The information contained on these pages is not comprehensive. It should not be considered medical advice and does not take the place your physician's advice. Although AA&MDSIF strives to provide accurate and up-to-date information, it does not guarantee the accuracy or currency of this information.